After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
ANI Pharmaceuticals Inc is listed on the NASDAQ in the Healthcare sector while operating in the Drug Manufacturers – Specialty & Generic industry. The current market capitalization of ANI Pharmaceuticals Inc is $1.31B. A total of 0.51 million shares were traded on the day, compared to an average of 259.32K shares.
In the most recent transaction, Cook Meredith sold 250 shares of ANIP for 59.62 per share on Aug 13 ’24. After the transaction, the SR. VP, GENERAL COUNSEL & SEC. now owns 56,988 company shares. In a previous transaction on Jul 18 ’24, Shanmugam Muthusamy sold 2,743 shares at 62.00 per share. ANIP shares that HEAD OF R&D, COO-NOVITIUM OPS owns now total 632,620.
Among the insiders who sold shares, Shanmugam Muthusamy disposed of 22,000 shares on Jul 16 ’24 at a per-share price of $64.27. This resulted in the HEAD OF R&D, COO-NOVITIUM OPS holding 649,620 shares of ANIP after the transaction. In another insider transaction, Shanmugam Muthusamy sold 14,257 shares at $63.16 per share on Jul 17 ’24. Company shares held by the HEAD OF R&D, COO-NOVITIUM OPS now total 635,363.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, ANIP has a high of $70.81 and a low of $48.20.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. ANIP’s latest balance sheet shows that the firm has $100.30M in Cash & Short Term Investments as of fiscal 2021. There were $287.37M in debt and $87.54M in liabilities at the time. Its Book Value Per Share was $21.63, while its Total Shareholder’s Equity was $358.74M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ANIP is Buy with a score of 4.80.
